Stents Market Research Reports & Industry Analysis
Stents are small, expandable mesh tubes commonly used in medical procedures to open narrowed or blocked blood vessels, restoring normal blood flow. The global stent market is growing due to technological advancements, the increasing prevalence of cardiovascular diseases, and a rising aging population. To help stakeholders gain an in-depth understanding of the market, MarketResearch.com provides a comprehensive collection of stents market research reports produced by expert analysts at a variety of leading firms.
New Stent Market Data to Guide Your Strategy
- Find reports spanning a wide range of markets such as coronary stents, drug-eluting stents, peripheral stents, and more.
- Use our research to quickly understand key market drivers and challenges, market forecasts, and the competitive landscape.
- In addition, learn about technological innovations such as the development of bioresorbable stents and the integration of advanced materials.
Gain a Competitive Edge with MarketResearch.com
MarketResearch.com provides the insights needed for informed decision-making in today’s competitive, fast-paced business environment. Our stents market research reports serve as a solid foundation of data, giving executives, consultants, and strategists a renewed sense of clarity and objectivity. Explore our stents industry reports today to get started.
Stents Industry Research & Market Reports
-
Coatings for Medical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Anti-Microbial, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$7.7 Billion by the end ... Read More
-
Vascular Guidewires
... CAGR of 5.5% over the analysis period 2024-2030. Coronary Guidewires, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$786.2 Million by the end of the analysis ... Read More
-
Coronary Guidewires
... CAGR of 4.4% over the analysis period 2024-2030. Nitinol-Based, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$550.2 Million by the end of the analysis period. ... Read More
-
Drug-Eluting Stents
... CAGR of 5.8% over the analysis period 2024-2030. Polymer-Free, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.9 Billion by the end of the analysis period. ... Read More
-
Intracranial Stents
... CAGR of 12.9% over the analysis period 2024-2030. Self-Expanding Stents, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$594.0 Million by the end of the analysis ... Read More
-
Neurovascular Stents
... CAGR of 9.7% over the analysis period 2024-2030. Carotid Artery Stents, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Gastrointestinal Stents
... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More
-
Laryngeal Stents
... CAGR of 6.2% over the analysis period 2024-2030. Self-Expandable Stents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$61.6 Million by the end of the analysis ... Read More
-
Drug Device Combination Products
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Transdermal Patches, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$53.4 Billion by the ... Read More
-
Pressure Guidewires
... CAGR of 8.6% over the analysis period 2024-2030. Flat Tipped Pressure Guidewires, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Peripheral Vascular Devices
... at a CAGR of 4.0% over the analysis period 2024-2030. Angioplasty Stents, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.1 Billion by the end of ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
Guidewires
... 4.2% over the analysis period 2024-2030. Coronary Guidewires, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$402.6 Million by the end of the analysis period. Growth ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Coronary Stents
... CAGR of 5.4% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.6 Billion by the end of the ... Read More
-
Kidney Stone Management Devices
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end ... Read More
-
Lacrimal Duct Stent Tubes
... 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Bicanalicular Tubes, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$35.0 Million by the ... Read More
-
Venous Stents
... CAGR of 8.4% over the analysis period 2024-2030. Iliac Vein Stent Technology, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Airway/Lung Stents
... CAGR of 5.4% over the analysis period 2024-2030. Tracheal, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$96.6 Million by the end of the analysis period. ... Read More
-
Transradial Access Products
... at a CAGR of 4.6% over the analysis period 2024-2030. Catheters, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Non-Vascular Stents
... CAGR of 5.1% over the analysis period 2024-2030. Urology Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
Global Embolic Protection Devices Market 2025-2029
... protection devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
2025 Global Forecast for Myocardial Fibrosis Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
2025 Global Forecast for Lung Stent Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in ... Read More
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
... the geriatric demographic, coupled with a notable increase in patients suffering from chronic conditions such as diabetes and cardiovascular diseases, is projected to drive the market for drug-device combination products significantly. Additionally, the steady rise ... Read More
Research Assistance
